Seroatlas · Human Serome Atlas

IRF9

Interferon regulatory factor 9

Also known as: IRF9_HUMAN, ISGF3G

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q00978
Gene
IRF9
Ensembl
ENSG00000213928
Chromosome
14
Canonical length
393 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
Subcellular location
Cytosol

OverviewNCBI Gene

This gene encodes a member of the interferon regulatory factor (IRF) family, a group of transcription factors with diverse roles, including virus-mediated activation of interferon, and modulation of cell growth, differentiation, apoptosis, and immune system activity. Members of the IRF family are characterized by a conserved N-terminal DNA-binding domain containing tryptophan (W) repeats. Mutations in this gene result in Immunodeficiency 65. [provided by RefSeq, Jul 2020]

Canonical amino-acid sequenceUniProt

393 residues, UniProt reviewed canonical sequence.

>Q00978|IRF9
     1  MASGRARCTR KLRNWVVEQV ESGQFPGVCW DDTAKTMFRI PWKHAGKQDF REDQDAAFFK
    61  AWAIFKGKYK EGDTGGPAVW KTRLRCALNK SSEFKEVPER GRMDVAEPYK VYQLLPPGIV
   121  SGQPGTQKVP SKRQHSSVSS ERKEEEDAMQ NCTLSPSVLQ DSLNNEEEGA SGGAVHSDIG
   181  SSSSSSSPEP QEVTDTTEAP FQGDQRSLEF LLPPEPDYSL LLTFIYNGRV VGEAQVQSLD
   241  CRLVAEPSGS ESSMEQVLFP KPGPLEPTQR LLSQLERGIL VASNPRGLFV QRLCPIPISW
   301  NAPQAPPGPG PHLLPSNECV ELFRTAYFCR DLVRYFQGLG PPPKFQVTLN FWEESHGSSH
   361  TPQNLITVKM EQAFARYLLE QTPEQQAAIL SLV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IRF9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
58 nTPM

Expression across tissuesHPA

Tissue

  • spleen: 58 nTPM
  • basal ganglia: 37 nTPM
  • hypothalamus: 37 nTPM
  • blood vessel: 36 nTPM
  • midbrain: 36 nTPM
  • spinal cord: 35 nTPM

Single-cell type

  • oligodendrocyte progenitor cells: 55 nCPM
  • microglia: 50 nCPM
  • astrocytes: 30 nCPM
  • ependymal cells: 26 nCPM
  • bergmann glia: 22 nCPM
  • oligodendrocytes: 19 nCPM

Immune cell

  • neutrophil: 181 nTPM
  • basophil: 171 nTPM
  • eosinophil: 104 nTPM
  • T-reg: 102 nTPM
  • total PBMC: 99 nTPM
  • non-classical monocyte: 99 nTPM

Brain region

  • medulla oblongata: 34 nTPM
  • spinal cord: 32 nTPM
  • white matter: 30 nTPM
  • thalamus: 24 nTPM
  • midbrain: 24 nTPM
  • hypothalamus: 23 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IRF9.

Disease | AllUniProt

Conditions IRF9 is implicated in, by any mechanism.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.45
gnomAD pLI
0.61
gnomAD missense Z
1.57
DepMap mean gene effect
-0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IRF9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IRF9 as an antibody target. Whether an autoantibody or antibody against IRF9 could matter depends on whether native IRF9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IRF9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label IRF9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IRF9. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...